Skip to Main content Skip to Navigation
Journal articles

Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis.

Abstract : The involvement of estrogen receptor beta (ERbeta) in prostate carcinogenesis has been hypothesized. Several reports have shown that ERbeta expression was decreased when prostate cells undergo neoplastic transformation, suggesting that it could play a tumor-suppressor role. By restoring ERbeta expression in prostatic carcinoma cells by adenoviral delivery, we aimed to test this hypothesis. We observed that ERbeta strongly inhibited the invasiveness and the growth of these cells. In addition, ERbeta cells were undergoing apoptosis, as shown by quantification of Bax, poly(ADP-ribose) polymerase and caspase-3 expression. Our data suggest that ERbeta acts as a tumor-suppressor by its anti-proliferative, anti-invasive and pro-apoptotic properties.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-00143968
Contributor : Gwendal Lazennec Connect in order to contact the contributor
Submitted on : Monday, April 30, 2007 - 2:53:22 PM
Last modification on : Tuesday, August 2, 2022 - 3:46:47 AM
Long-term archiving on: : Wednesday, April 7, 2010 - 12:34:04 AM

Identifiers

Collections

Citation

Jennifer Cheng, Eun Jig Lee, Laird D. Madison, Gwendal Lazennec. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis.. FEBS Letters, Wiley, 2004, 566 (1-3), pp.169-72. ⟨10.1016/j.febslet.2004.04.025⟩. ⟨inserm-00143968⟩

Share

Metrics

Record views

35

Files downloads

628